Pituitary Drugs Study Notes

Pituitary Drugs

Instructor Information

  • Presenter: Rachel Feiman, MSN, RN

  • Course: NUR2012


Learning Outcomes

  • Mechanisms of Action: Describe the mechanisms of action, therapeutic effects, and clinical indications of pituitary drugs and their roles in endocrine regulation and disease management.

  • Desmopressin vs. Vasopressin: Differentiate between desmopressin and vasopressin in treating Diabetes Insipidus (DI), nocturnal enuresis, and shock, highlighting their effects on fluid balance and vasoconstriction.

  • Pituitary Hormones: Differentiate between anterior and posterior pituitary hormones.

  • Cosyntropin: Explain the role of cosyntropin in diagnosing adrenal insufficiency.

  • Side Effects and Nursing Considerations: Evaluate potential side effects and nursing considerations when administering pituitary drugs.


Neuroendocrine System

  • Components:

    • Pituitary Gland: Major endocrine gland that communicates with the hypothalamus.

    • Feedback Mechanisms:

    • Negative feedback loop regulates hormonal levels.

Anterior Pituitary Hormones
  • Key Hormones:

    • TSH: Thyroid-stimulating hormone

    • ACTH: Adrenocorticotropic hormone

    • LH: Luteinizing hormone

    • FSH: Follicle-stimulating hormone

    • GH: Growth hormone

    • Prolactin: PRL

    • Endorphins: Natural pain relievers

Posterior Pituitary Hormones
  • Key Hormones:

    • Oxytocin

    • Vasopressin (also known as Antidiuretic hormone or ADH)


Anterior Pituitary - Cosyntropin

  • Use:

    • Diagnoses adrenal insufficiency, particularly in Addison's Disease.

    • Mechanism: Mimics adrenocorticotropic hormone (ACTH).

    • Effects: Stimulates the adrenal cortex to release cortisol.

  • Cortisol Functions:

    • Provides anti-inflammatory effects.

    • Promotes renal retention of sodium to maintain fluid balance.


Anterior Pituitary - Somatropin

  • Indications:

    • Treatment of hypopituitary dwarfism.

    • Growth hormone deficiency.

    • Muscle wasting related to HIV.

  • Administration:

    • Given subcutaneously (SQ) and should not be shaken.

  • Contraindications (C/I):

    • Closure of epiphyses (growth plates).

    • Prader-Willi Syndrome.

  • Adverse Effects (AE/SE):

    • Hyperglycemia

    • Hypothyroidism

    • Hypertension

    • Pancreatitis

    • Arthralgia (joint pain)

  • Patient Education:

    • Monitor for side effects, especially glucocorticoid interaction.


Anterior Pituitary - Octreotide

  • Use:

    • Treats gigantism and acromegaly.

  • Clinical Presentation:

    • Physical features include a prominent forehead, enlarged nose, enlarged lips and tongue, prominent chin and jaw.

  • Mechanism of Action (MOA):

    • Inhibits the release of growth hormone from the pituitary gland.

  • Adverse Effects (AE/SE):

    • Sweating, hyperglycemia, pancreatitis, ileus (intestinal blockage), hypoglycemia, and prolonged QT interval.

  • Nursing Considerations (N/C):

    • Monitor gastrointestinal (GI) assessment and skin turgor.

    • Special attention for diabetic patients.


Posterior Pituitary - Oxytocin and Antidiuretic Hormone (ADH)

  • Antidiuretic Hormone (ADH):

    • Also known as vasopressin; prevents excessive urine production and promotes water retention.

    • Vasoconstriction: Increases blood pressure by constricting blood vessels.

Diabetes Insipidus (DI)
  • Explanation:

    • Characterized by partial or complete deficiency of ADH, leading to excessive thirst (polydipsia) and increased urine production (polyuria).

  • Nursing Considerations:

    • Monitor specific gravity of urine, input/output (I/O), vital signs, weight, and laboratory results.


Posterior Pituitary - Vasopressin

  • Uses:

    • Treatment of Diabetes Insipidus.

    • Mimics endogenous ADH.

    • Increases water reabsorption and reduces water excretion, concentrating urine.

  • Adverse Effects (AE/SE):

    • Potential for water intoxication, myocardial infarction (MI), and blood pressure issues.

  • Nursing Considerations:

    • Instruct patients to drink 1-2 glasses of water at the time of administration.

    • Monitor the intravenous (IV) site closely.


Posterior Pituitary - Desmopressin (DDAVP)

  • Administration Routes:

    • Available PO (orally), SL (sublingually), SUBQ (subcutaneously), IV (intravenously), and IN (intranasally).

  • Uses:

    • Treatment for Diabetes Insipidus.

    • Also used for nocturnal enuresis and Von Willebrand disease.

  • Mechanism of Action (MOA):

    • Mimics endogenous ADH function, similar to vasopressin.

  • Adverse Effects (AE/SE):

    • Water intoxication, headaches, seizures.

  • Nursing Considerations:

    • Monitor for headaches and assess labs, urine osmolality, I/O, weight, and signs/symptoms of dehydration.

    • Be careful with the administration routes to prevent complications related to absorption.


Nocturnal Enuresis Definition

  • Primary Nocturnal Enuresis: Occurs when a child has never attained long-term bladder control and has not stayed dry in bed for a prolonged period.

  • Secondary Nocturnal Enuresis: Develops in children or adults who had previously achieved bladder control but then began to wet the bed again after a period of dryness.